Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5457]
News [12691]
Articles [177]
Editorials [5]
Conferences [249]
elearning [17]
Pegargiminase-pemetrexed-platinum triplet therapy prolongs survival in non...
Prof Peter Szlosarek - Barts Cancer Institute, London, UK
Pegargiminase-pemetrexed-platinum triplet therapy prolongs survival in non-epithelioid pleural mesothelioma ( Prof Peter Szlosarek - Barts Cancer Institute, London, UK )
26 Apr 2023
Breast and emerging indications for IORT
Dr David Martinez Perez - AUNA, Lima, Peru
Breast and emerging indications for IORT ( Dr David Martinez Perez - AUNA, Lima, Peru )
26 Apr 2023
The advantages of IORT for early breast cancer treatment
Dr David Martinez Perez - AUNA, Lima, Peru
The advantages of IORT for early breast cancer treatment ( Dr David Martinez Perez - AUNA, Lima, Peru )
26 Apr 2023
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC...
Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC ( Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA )
26 Apr 2023
Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in...
Dr Jason Luke - University of Pittsburgh, Pittsburgh, USA
Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours ( Dr Jason Luke - University of Pittsburgh, Pittsburgh, USA )
26 Apr 2023
VT3989 is safe and well tolerated in patients with advanced malignant...
Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023
Childhood cancer: The surprising scientific facts
Dr Mlis Ratha - Calmette Hospital, Phnom Penh, Cambodia
Childhood cancer: The surprising scientific facts ( Dr Mlis Ratha - Calmette Hospital, Phnom Penh, Cambodia )
25 Apr 2023
Choosing Wisely in medical oncology
Dr Omar AbdiHamid - Garissa Cancer Center, Garissa, Kenya
Choosing Wisely in medical oncology ( Dr Omar AbdiHamid - Garissa Cancer Center, Garissa, Kenya )
25 Apr 2023
Hemopathy burden at National Cancer Center
Dr Kao Vannarith - Calmette Hospital, Phnom Penh, Cambodia
Hemopathy burden at National Cancer Center ( Dr Kao Vannarith - Calmette Hospital, Phnom Penh, Cambodia )
25 Apr 2023
To avoid unnecessary second surgery in differentiated thyroid cancer
Dr Thou Sarameth - Calmette Hospital, Phnom Penh, Cambodia
To avoid unnecessary second surgery in differentiated thyroid cancer ( Dr Thou Sarameth - Calmette Hospital, Phnom Penh, Cambodia )
25 Apr 2023
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant...
Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023
Durable effect of imatinib and metronomic chemotherapy with capecitabine in...
Dr Sana Al-Sukhun - Al Hyatt Oncology Practice, Amman, Jordan
Durable effect of imatinib and metronomic chemotherapy with capecitabine in pancreatic carcinoma ( Dr Sana Al-Sukhun - Al Hyatt Oncology Practice, Amman, Jordan )
21 Apr 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation